Time to think again over EU scrutiny measure: not even PMA would have stopped PIP scandal
This article was originally published in Clinica
Executive Summary
Production of the fraudulent PIP breast implants could not have been avoided even with a competent authority-controlled premarket approval process, so any calls for this product appraisal system to be introduced in Europe are driven by “wrong assumptions”.